Delcath Systems, Inc. (DCTH)
-NasdaqCM 0.41 
0.01(3.22%) May 17, 4:00PM EDT
| Prev Close: | 0.40 |
|---|
| Open: | 0.41 |
|---|
| Bid: | 0.19 x 100 |
|---|
| Ask: | 1.00 x 7000 |
|---|
| 1y Target Est: | 0.85 |
|---|
| Beta: | 2.51 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 0.39 - 0.42 |
|---|
| 52wk Range: | 0.38 - 2.43 |
|---|
| Volume: | 1,545,493 |
|---|
| Avg Vol (3m): | 3,341,040 |
|---|
| Market Cap: | 37.73M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.71 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Delcath Systems, Inc. To Contact The FirmPR Newswire(Sat May 18)
- Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Delcath Systems, Inc. of Class Action Lawsuit and Upcoming Deadline -- DCTHGlobeNewswire(Fri May 17)
- DELCATH SYSTEMS, INC. FinancialsEDGAR Online Financials(Fri May 17)
- DELCATH SYSTEMS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online(Fri May 17)
- DELCATH SYSTEMS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online(Mon May 13)
- SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $250,000 From Investment in Delcath Systems, Inc. to Contact Brower Piven Before the July 8, 2013 Lead Plaintiff Deadline -- DCTHGlobeNewswire(Fri May 10)
- Delcath Systems, Inc. Sued by InvestorPR Newswire(Fri May 10)
- Delcath Systems Shareholder Alert: Briscoe Law and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and DirectorsBusiness Wire(Fri May 10)
- Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Delcath Systems, Inc. (NASDAQ: DCTH)Marketwired(Fri May 10)
- Today’s Research on DCTH, AKRX, ASTX, BMRN, and FRXAccesswire(Fri May 10)
- DELCATH SYSTEMS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhEDGAR Online(Thu May 9)
- DELCATH SYSTEMS, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online(Thu May 9)
- Delcath Systems Management Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Wed May 8)
- Pomerantz Law Firm Has Filed a Class Action Against Delcath Systems, Inc. and Certain Officers -- DCTHGlobeNewswire(Wed May 8)
- Delcath Systems, Inc. Earnings Call scheduled for 4:30 pm ET todayCCBN(Wed May 8)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 50.28 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.42 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.11 |
|---|
| Mean Recommendation*: | 3.8 |
|---|
| PEG Ratio (5 yr expected): | -0.06 |
|---|
Business Summary
Delcath Systems, Inc. operates as a specialty pharmaceutical and medical device company focusing on the field of oncology. The companys proprietary technology enables the administration of high-dose chemotherapy and other therapeutic agents ...
View More